Thermo Fisher receives US market clearance for MRSA test
A test to screen patients for MRSA, or methicillin-resistant Staphylococcus aureus, developed by Thermo Fisher Scientific Inc., has been granted U.S. market clearance. MRSA, also known as superbug, is a deadly bacteria that has been increasing its prevalence in America and is a cause for concern due to its resistance to common antibiotics.
- Quidel receives CLIA waiver for QuickVue RSV test
- InfraScan receives CE Mark for handheld detector
- FDA clearance to MiCardia for marketing Dynaplasty™ Annuloplasty devices
- FDA delays clearance of POC Skin Cholesterol Test
